Researchers develop precise drugs to target HIV's Nef protein
Can't see this email? View it online
   
  HIV/AIDS  
  The latest HIV/AIDS news from News Medical  
 Scientists discover a key mechanism used by human herpesvirus 8 to induce cancerScientists discover a key mechanism used by human herpesvirus 8 to induce cancer
 
Cleveland Clinic researchers have discovered a key mechanism used by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer.
 
 
 Researchers develop precise drugs to target HIV's Nef proteinResearchers develop precise drugs to target HIV's Nef protein
 
A team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity.
 
   Research validates concurrent use of HIV medications and gender-affirming hormone therapyResearch validates concurrent use of HIV medications and gender-affirming hormone therapy
 
New research definitively shows that HIV antiretrovirals can be taken together with gender-affirming hormone therapy without changing how well either drug works.
 
   "Copy-paste" genetic mechanism increases the genetic diversity of malaria parasite"Copy-paste" genetic mechanism increases the genetic diversity of malaria parasite
 
By dissecting the genetic diversity of the most deadly human malaria parasite – Plasmodium falciparum – researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have identified a mechanism of 'copy-paste' genetics that increases the genetic diversity of the parasite at accelerated time scales.
 
   Study shows semaglutide as a safe and effective therapy for MASLD in people with HIVStudy shows semaglutide as a safe and effective therapy for MASLD in people with HIV
 
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.
 
 Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender women
 
Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender womenThe monthly dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine were each found to be safe for HIV prevention among cisgender women who started using one of them in their second trimester of pregnancy, according to findings presented today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.
 
 
 Social workers bridge the gap in HIV care for hospitalized patients in Tanzania
 
Social workers bridge the gap in HIV care for hospitalized patients in TanzaniaResearchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost.
 
 
 U-M research offers a new path forward in the development of anti-HIV drugs
 
U-M research offers a new path forward in the development of anti-HIV drugsA team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity.